Jonathan Robert Hunt insider trades

Open-market stock purchases and sales by Jonathan Robert Hunt, Chief Accounting Officer at Perspective Therapeutics, Inc, from SEC Form 4 filings since Jun 18, 2019.

Track record: 38% of 8 scored buys are up 5% or more since purchase, averaging +17%.

Recent trades

DateStockTradeValue
Mar 2, 2026CATX Perspective Therapeutics, IncBought (not open market)—
Nov 13, 2025CATX Perspective Therapeutics, IncBought$22.3K

Companies traded

  • CATX Perspective Therapeutics, Inc: 9 buys, last Mar 2, 2026
  • ISR Isoray, Inc: 6 buys, last Dec 5, 2022

Get free alerts when Jonathan Robert Hunt files a new trade →